BSEM · Company research
BioStem Technologies, Inc. Common Stock (BSEM): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| BioStem Technologies, Inc. SEC Filing (Oct 13, 2026) - Stock Titan | BioStem Technologies, Inc. SEC Filing (Oct 13, 2026) Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| BioStem Technologies (Nasdaq:BSEM) - Stock Analysis - Simply Wall Street | BioStem Technologies (Nasdaq:BSEM) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Oct 12, 2026 | neutral | 0 | 0.6 |
| At $2 a share, BioStem Technologies (BSEM) CEO exercised options for 250,000 shares. - Stock Titan | At $2 a share, BioStem Technologies (BSEM) CEO exercised options for 250,000 shares. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| At $2 a share, BioStem Technologies (BSEM)'s COO exercises options to acquire 250,000 shares. - Stock Titan | At $2 a share, BioStem Technologies (BSEM)'s COO exercises options to acquire 250,000 shares. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| BioStem Technologies Completes $3 Million Private Placement Financing - The Globe and Mail | BioStem Technologies Completes $3 Million Private Placement Financing The Globe and Mail | View source ↗ | The Globe and Mail | Oct 1, 2026 | neutral | 0 | 0.6 |
| Up to $40 million in shares could be sold by BioStem. It does not have to use the facility. - Stock Titan | Up to $40 million in shares could be sold by BioStem. It does not have to use the facility. Stock Titan | View source ↗ | Stock Titan | Sep 18, 2026 | neutral | 0 | 0.6 |
| Biostem Technologies (BSEM) Stock Chart and Price History 2026 - MarketBeat | Biostem Technologies (BSEM) Stock Chart and Price History 2026 MarketBeat | View source ↗ | MarketBeat | Aug 21, 2026 | neutral | 0 | 0.6 |
| Biostem Technologies (BSEM) Stock Price, News & Analysis - MarketBeat | Biostem Technologies (BSEM) Stock Price, News & Analysis MarketBeat | View source ↗ | MarketBeat | Aug 21, 2026 | neutral | 0 | 0.6 |
| BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance | BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 12, 2026 | neutral | 0 | 0.6 |
| $BSEM ($BSEM) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative | $BSEM ($BSEM) Releases Q2 2026 Earnings, Stock Rises Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 12, 2026 | neutral | 0 | 0.6 |
| BioStem Technologies Inc (BSEM) Q2 2026 Earnings Report Preview: What To Expect - Yahoo Finance | BioStem Technologies Inc (BSEM) Q2 2026 Earnings Report Preview: What To Expect Yahoo Finance | View source ↗ | Yahoo Finance | Aug 11, 2026 | neutral | 0 | 0.6 |
| BioStem Technologies: BSEM Stock Price Quote & News - Robinhood | BioStem Technologies: BSEM Stock Price Quote & News Robinhood | View source ↗ | Robinhood | Aug 8, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Aug 8, 2026 | neutral | 0 | 0.6 |
| BSEM Stock Price and Chart — NASDAQ:BSEM - TradingView | BSEM Stock Price and Chart — NASDAQ:BSEM TradingView | View source ↗ | TradingView | Aug 7, 2026 | neutral | 0 | 0.6 |
| BioStem Technologies Expands Board with Three Appointments as Nasdaq Uplisting Remains a Key Objective (BSEM) - Yahoo Finance | BioStem Technologies Expands Board with Three Appointments as Nasdaq Uplisting Remains a Key Objective (BSEM) Yahoo Finance | View source ↗ | Yahoo Finance | Jun 9, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.